Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is 0.46 as of 2026-10-06T13:40:56.651Z.
Calculation as of: 2026-10-06T13:40:56.651Z.
Quote observation: 2026-10-06T13:40:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8ed0f9e65bb83f7068851461510a5a76fbd0cacd9861b16543d2412dd847d006
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
0.46
SECTOR MEDIAN · INDUSTRIALS
2.97
median of 313 covered companies
CURRENT VS SECTOR MEDIAN
-84.51%
vs the sector median at left
Market Cap
$2.03B
PB Ratio
4.11
TTM Avg
3.15
3Y Avg
2.13
5Y Avg
1.82
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arxis, Inc. Class A Common Stock (ARXS) | $2.03B | 0.46 | N/A | N/A | N/A |
| Preformed Line Products Company (PLPC)vs › | $2.03B | 4.11 | 3.15 | 2.13 | 1.82 |
| Werner Enterprises, Inc. (WERN)vs › | $2.01B | 1.49 | 1.51 | 1.49 | 1.71 |
| Allient Inc. (ALNT)vs › | $2.04B | 6.54 | 4.08 | 2.55 | 2.60 |
| Trinity Industries, Inc. (TRN)vs › | $2.09B | 1.83 | 2.37 | 2.36 | 2.30 |
| Allegiant Travel Company (ALGT)vs › | $2.09B | 1.17 | 1.41 | 1.08 | 1.35 |
| ADARx Pharmaceuticals, Inc. (ADRX)vs › | $1.90B | N/A | N/A | N/A | N/A |
| Flywire Corp (FLYW)vs › | $2.20B | 2.70 | 2.25 | 2.64 | 4.05 |
| Enerpac Tool Group Corp. (EPAC)vs › | $1.86B | 4.38 | 4.68 | 5.37 | 4.71 |
| Cimpress plc (CMPR)vs › | $1.83B | N/A | 28.64 | 34.70 | 27.13 |
P/B Ratio
0.46
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
